English
-
6 Feb, 2025
Spago Nanomedical year-end report January-December, 2024
-
15 Jan, 2025
Spago Nanomedical article on SPAGOPIX-01 clinical results accepted for publication in Investigative Radiology
-
18 Dec, 2024
Second patient group successfully dosed in Spago Nanomedical’s Phase I/IIa study Tumorad-01
-
6 Nov, 2024
Spago Nanomedical interim report January-September 2024
-
21 Oct, 2024
Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2025
-
1 Oct, 2024
Spago Nanomedical in new phase with full focus on the Tumorad program
-
27 Aug, 2024
Spago Nanomedical’s Phase I/IIa study Tumorad-01 continues following successful treatment completion of first patient group
-
21 Aug, 2024
Spago Nanomedical interim report January-June 2024
-
10 Jun, 2024
Bulletin from the 2024 Annual General Meeting of Spago Nanomedical AB
-
31 May, 2024
Spago Nanomedical announces outcome of the exercise of warrants series TO12